CircRFWD3 promotes HNSCC metastasis by modulating miR-27a/b/PPARγ signaling
Open Access
- 11 June 2022
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 8 (1) , 1-14
Abstract
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world, the 5-year survival rate of patients with HNSCC is still about 50% due to frequent metastasis and recurrence. Circular RNAs (circRNAs) have been characterized as key regulators of gene expression in numerous malignancies. However, the role of circRNA in HNSCC metastasis remains largely unknown. Here, we demonstrated that the circRFWD3 was significantly upregulated in HNSCC tissues and cell lines by circRNA microarray analysis and qPCR. Notably, high expression of circRFWD3 is related to highly aggressive HNSCC cell lines and lymph node metastasis in HNSCC patients. After that, Sanger sequencing, RNase R, and actinomycin D assay were performed to verify the ring structure of circRFWD3. Then functional experiments found it could promote the metastasis of HNSCC cells both in vitro and in vivo. Mechanistically, a dual-luciferase reporter assay, FISH, RIP, RNA pull-down, RNA-seq, and western blot experiments were employed and found that circRFWD3 served as a miRNAs sponge for miR-27a/27b, leading to the upregulation of PPARγ, and then promoted HNSCC metastasis via NF-κB/MMP13 pathway. Finally, ISH and IHC were carried out to determine the expression levels and clinical significances of circRFWD3 and PPARγ in clinical cohorts of HNSCC. According to the analysis results from two independent HNSCC cohorts, upregulated expression of circRFWD3 and PPARγ were positively associated with worse survival in patients with HNSCC. Overall, our results uncover that circRFWD3 acts a critical role in promoting the aggressiveness of HNSCC cells and is a prognostic marker for the disease, indicating that circRFWD3 may act as a potential therapeutic target in HNSCC.Keywords
This publication has 38 references indexed in Scilit:
- Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based studyEuropean Journal of Cancer, 2015
- Predicting effective microRNA target sites in mammalian mRNAseLife, 2015
- Comprehensive genomic characterization of head and neck squamous cell carcinomasNature, 2015
- NF-κB, an Active Player in Human CancersCancer Immunology Research, 2014
- MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient SurvivalPLOS ONE, 2012
- Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period AnalysisThe Oncologist, 2010
- Making RISCTrends in Biochemical Sciences, 2010
- Expression Profiles and Clinical Correlations of Degradome Components in the Tumor Microenvironment of Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2010
- miRBase: tools for microRNA genomicsNucleic Acids Research, 2007
- GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activationBritish Journal of Pharmacology, 2004